Logo image
Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease
Editorial   Open access   Peer reviewed

Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease

Ali Alsoudani and Akhilesh Swaminathan
Alimentary pharmacology & therapeutics
30/03/2026
Handle:
https://hdl.handle.net/10523/50367

Abstract

editorial Perianal fistulising Crohn's disease disease activity monitoring
Perianal fistulising Crohn's disease (PFCD) affects up to 20% of patients with Crohn's disease (CD) and is a complex and challenging form of CD that can result in a significant illness burden. Despite recent advances in PFCD classification systems, disease activity can be challenging to monitor on an ongoing basis when compared to luminal CD where biomarkers, imaging and colonoscopy are readily utilised in a "treat to target" approach.
url
https://doi.org/10.1111/apt.70640View
Published (Version of record) Open All Rights Reserved  — All items in OUR Archive are provided for research purposes and private study and are protected by copyright with all rights reserved unless otherwise indicated.

Metrics

1 Record Views

Details

Logo image